Matriks Biotek

Developer of ELISA kits to monitor biological drugs

placeAnkara, Ankara, Turkey calendar_todayFounded 2002 language matriksbiotek.com

Social engagement

Social engagement: 2K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%

Recent activity

16 Jun 2026
Product launch
SHIKARI® Q-MIR ELISA kits for Mirikizumab monitoring
16 Dec 2025
Partnership
Mabriks Biotek
Coming soon